<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>D.C. Law Library - D.C. Act 23-588. Insulin and Diabetes Device Affordability Amendment Act of 2020.</title>
    <meta property="st:title" content="D.C. Act 23-588. Insulin and Diabetes Device Affordability Amendment Act of 2020."/>
    <meta name="description" content="Browse the laws and code of the District of Columbia"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
        var _paq = _paq || [];
        _paq.push(['trackPageView']);
        _paq.push(['enableLinkTracking']);
        (function() {
            var u="//analytics.code.dccouncil.us/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', 1]);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
        })();
        
        window.searchHost = 'https://search.code.dccouncil.us';
        window.queryUrl = '/v1/search';
    </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <a href="http://dccouncil.us">
          <img src="/css/header_logo.png" alt="DC Seal" class="header_logo"/>
        </a>
        <h1 id="sitename">
          <a href="/dc/council/acts/23-588.html">D.C. Act 23-588. Insulin and Diabetes Device Affordability Amendment Act of 2020.</a>
        </h1>
        <div class="right no-print search" id="search"> </div>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col3 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code" data-search-default="true"/>
            <li data-search-path="library" data-search-heading="All Documents">↪ <a href="/">D.C. Law Library</a></li>
            <li data-search-path="library|dclaws" data-search-heading="D.C. Laws">↪ <a href="/dclaws/">D.C. Laws Codified in the D.C. Code</a></li>
            <li data-search-path="library|dclaws|23" data-search-heading="">↪ <a href="/dclaws/23/">Council Period 23 (2019-2020)</a></li>
            <li data-search-path="library|dclaws|23|permanent" data-search-heading="">↪ <a href="/dclaws/23/permanent/">Permanent Laws</a></li>
            <li data-search-path="library|dclaws|23|permanent|pending" data-search-heading="">↪ <a href="/dclaws/23/permanent/pending/">Acts pending congressional review</a></li>
            <li data-search-path="library|dclaws|23|permanent|pending|D.C. Act 23-588" data-search-heading="D.C. Act 23-588">↪ D.C. Act 23-588. Insulin and Diabetes Device Affordability Amendment Act of 2020.</li>
          </ul>
          <div class="document-info">
            <h2>Law Information</h2>
            <dl>
              <dt>Cites</dt>
              <dd>D.C. Act 23-588 (<a class="internal-link" href="https://lims.dccouncil.us/downloads/LIMS/45694/Signed_Act/B23-0920-Signed_Act.pdf">PDF</a>)<br/>68 DCR 001151<br/></dd>
              <dt>Effective</dt>
              <dd>Mar. 15, 2021 (Projected)</dd>
              <dt>Legislative History (<a href="https://lims.dccouncil.us/Legislation/B23-0920">LIMS</a>)</dt>
            </dl>
          </div>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/acts/23-588.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/acts/23-588.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <section class="pending_notice">
        This act is <strong>not yet codified</strong> in the D.C. Code because it is not yet effective as law. It is projected to become effective on Mar. 15, 2021.
      </section>
          <h1 id="/dc/council/acts/23-588.html">D.C. Act 23-588. Insulin and Diabetes Device Affordability Amendment Act of 2020.</h1>
          <section class="content">
            <p style="text-align: center;">AN ACT</p>
            <p style="font-style: italic">To amend the Specialty Drug Copayment Limitation Act of 2016 to impose a limit on the amount that a person must pay in copayment or coinsurance through a health benefit plan for a prescription for insulin.</p>
            <p>BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Insulin and Diabetes Device Affordability Amendment Act of 2020".</p>
            <p id="&#xA7;2"><span class="level-num">Sec. 2. </span>The Specialty Drug Copayment Limitation Act of 2016, effective April 7, 2017 (D.C. Law 21-248; D.C. Official Code § 48-855.01 <em>et seq.</em>), is amended as follows:</p>
            <p class="marginalia">Amend <a href="/dc/council/code/sections/48-855.01.html">§ 48-855.01</a></p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(a)">(a)</span> Section 2 (D.C. Official Code § 48-855.01) is amended as follows:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(1)">(1)</span> New paragraphs (3A) and (3B) are added to read as follows:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(3A)</span> "Diabetes device" means a legend device or non-legend device used to cure, diagnose, mitigate, prevent or treat diabetes or low blood sugar.  The term includes a blood glucose test strip, glucometer, continuous glucometer, lancet, lancing device, or insulin syringe.</p>
            <p class="text-indent-2">"<span class="level-num" id="">(3B)</span> "Diabetic ketoacidosis device" means a device that is a legend or non-legend device and used to screen for or prevent diabetic ketoacidosis. The term includes diabetic ketoacidosis devices prescribed and dispensed once during a policy year.".</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(a)(2)">(2)</span> A new paragraph (9A) is added to read as follows:</p>
            <p class="text-indent-2">"<span class="level-num" id="">(9A)</span> "Prescription insulin drug" means a prescription drug that contains insulin and is used to control blood glucose levels to treat diabetes.".</p>
            <p class="marginalia">Amend <a href="/dc/council/code/sections/48-855.02.html">§ 48-855.02</a></p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(b)">(b)</span> Section 3 (D.C. Official Code § 48-855.02) is amended by striking the phrase "Washington-Baltimore metropolitan area" and "inserting the phrase "Washington-Arlington-Alexandria, DC-VA-MD-WV metropolitan area" in its place.</p>
            <p class="marginalia">Amend <a href="/dc/council/code/sections/48-855.03.html">§ 48-855.03</a></p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(c)">(c)</span> Section 4 (D.C. Official Code § 48-855.03) is amended by striking the phrase "January 1, 2018" and inserting the phrase "January 1, 2018; except, that section 3a shall apply on January 1, 2022." in its place.</p>
            <p class="marginalia">New § 48-855.02a</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;2(d)">(d)</span> A new section 3a is added to read as follows:</p>
            <p id="">"<span class="level-num">Sec. 3a. </span>Insulin copayment or coinsurance limitation.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(a)</span> A health insurer that provides coverage for prescription insulin drugs pursuant to the terms of a health benefits plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $30, regardless of the quantity or type of covered prescription insulin drug used to fill the insured's prescription.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(b)</span> A health insurer that provides coverage for diabetes devices and diabetic ketoacidosis devices pursuant to the terms of a health benefits plan offered by the insurer, shall limit the total amount that an insured is required to pay for a 30-day supply of all medically necessary covered diabetes devices and diabetic ketoacidosis devices that are in accordance with the insured's diabetes treatment plan at an amount not to exceed $100.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(c)</span> Pursuant to subsections (a) and (b) of this section, prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices shall be covered without being subject to a deductible and any cost sharing paid by an insured shall be applied toward the insured's deductible obligation.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(d)</span> Nothing in this section prevents an insurer from reducing an insured's copayment or coinsurance by an amount greater than the amount specified in subsections (a) and (b) of this section.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(e)</span> On July 1 of each year, the limit on a required copayment or coinsurance an insured is required to pay under subsections (a) and (b) of this section shall increase by a percentage equal to the percentage change from the preceding year in the medical care component of the Consumer Price Index for All Urban Consumers, Washington-Arlington-Alexandria, DC-VA-MD-WV metropolitan area, as published by the Bureau of Labor Statistics of the United States Department of Labor.</p>
            <p class="text-indent-1">"<span class="level-num" id="">(f)</span> This section shall apply as of January 1, 2022.".</p>
            <p id="&#xA7;3"><span class="level-num">Sec. 3. </span>Fiscal impact statement.</p>
            <p>The Council adopts the fiscal impact statement in the committee report as the fiscal</p>
            <p>impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</p>
            <p id="&#xA7;4"><span class="level-num">Sec. 4. </span>Effective date.</p>
            <p>This act shall take effect following approval by the Mayor (or in the event of veto by the</p>
            <p>Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(l) of the District of Columbia Home Rule Act, approved December</p>
            <p>24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(l)), and publication in the District of Columbia Register.</p>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
